InMode (INMD) Net Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | 1,026.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,026.47% |
| Dec 31, 2025 | 712.34% |
| Sep 30, 2025 | -49.55% |
| Jun 30, 2025 | 338.70% |
| Mar 31, 2025 | 56.87% |
| Dec 31, 2024 | -182.95% |
| Sep 30, 2024 | 381.15% |
| Jun 30, 2024 | -143.09% |
| Mar 31, 2024 | -383.06% |
| Dec 31, 2023 | -49.52% |
| Sep 30, 2023 | -156.72% |
| Jun 30, 2023 | 49.15% |
| Mar 31, 2023 | 79.54% |
| Dec 31, 2022 | 2,485.57% |
| Sep 30, 2022 | -232.65% |
| Jun 30, 2022 | 1,525.74% |
| Mar 31, 2022 | -511.30% |
| Dec 31, 2021 | -69.36% |
| Sep 30, 2021 | 96.45% |
| Jun 30, 2021 | -116.13% |
| Mar 31, 2021 | -692.24% |
| Dec 31, 2020 | 88.26% |
| Sep 30, 2020 | -80.75% |
| Jun 30, 2020 | 96.42% |
| Mar 31, 2020 | 111.10% |
| Dec 31, 2019 | -198.89% |
| Sep 30, 2019 | 261.32% |
| Jun 30, 2019 | -0.50% |